DEFA14A: Masimo CEO Joe Kiani Addresses Proxy Fight and Potential Spinoff in Recent Interview

Masimo CEO Joe Kiani discusses the ongoing proxy fight with Politan Capital, the potential spinoff of the consumer business, and the launch of the Stork baby monitor in a recent interview.

Summary

• Masimo is engaged in a proxy fight with Politan Capital regarding board control.
• The company is considering a spinoff of its consumer business due to differing investor expectations between healthcare and consumer sectors.
• Masimo is launching the Stork baby monitor, a device using pulse oximetry to detect potential health issues in infants, priced at around $200-$300.
• The company aims to replicate its success in healthcare with a push-pull strategy in the consumer market, combining direct products and OEM partnerships.
• Masimo is launching a new generation Root product this year as an anniversary present to customers and stockholders.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While there are positive aspects like the Stork baby monitor and potential spinoff benefits, the ongoing proxy fight and associated costs create uncertainty.

Positives

• The Stork baby monitor has the potential to significantly impact infant health monitoring.
• The potential spinoff could unlock value by catering to different investor bases.
• Masimo's push-pull strategy has proven successful in the healthcare market.
• The new generation Root product will be an anniversary present to customers and stockholders.

Negatives

• The proxy fight with Politan Capital is consuming significant resources and management attention.
• The proposed solution of seating one Politan nominee will simply deadlock the Board.
• The spinoff could be perceived as a short-term solution that sacrifices long-term strategic goals.

Risks

• Uncertainties surrounding the potential separation of Masimo's Consumer Business.
• Potential actions by Politan in furtherance of its nomination of director candidates.
• The cost and management distraction attendant to Politan's nomination of director nominees.
• Risks detailed in Masimo's SEC filings, including factors that could cause actual results to differ materially from forward-looking statements.

Future Outlook

Masimo is evaluating a potential separation of its Consumer Business and plans to launch a new generation Root product this year. The company aims to expand its presence in the consumer market through a combination of direct products and OEM partnerships.

Management Comments

• Joe Kiani: 'Its a shame because were going to spend a lot of energy, a lot of money fighting this thing. But the shareholders will have to decide what they want for the future.'
• Joe Kiani: 'Short term, were a healthcare company, and our healthcare investors dont know how to deal with the consumer side of our business.'
• Joe Kiani: 'I started Masimo to be an OEM company, meaning I didnt want to make our own end user product. I wanted to be integrated in other peoples products.'

Industry Context

The potential spinoff reflects a broader trend of companies separating divisions to better cater to specific investor preferences. Masimo's entry into the consumer health market with the Stork baby monitor positions it to compete with existing players in the baby monitoring space, such as Owlet, while leveraging its expertise in medical-grade pulse oximetry.

Comparison to Industry Standards

• Masimo's Stork baby monitor aims to bring hospital-grade pulse oximetry to the consumer market, differentiating it from existing baby monitors that primarily focus on audio and video monitoring.
• The company's OEM strategy is similar to that of Dolby or Intel, where their technology is integrated into other companies' products.
• Masimo's success in the healthcare market, where it is a leading pulse oximeter company, provides a strong foundation for its expansion into the consumer market.

Stakeholder Impact

• Shareholders will be impacted by the outcome of the proxy fight and the potential spinoff.
• Customers may benefit from the launch of innovative products like the Stork baby monitor.
• Employees may experience changes depending on the outcome of the proxy fight and the potential spinoff.

Next Steps

• Masimo will file a proxy statement and GOLD proxy card with the SEC.
• The company will proceed with the 2024 Annual Meeting of Stockholders.
• Masimo will continue to evaluate the potential separation of its Consumer Business.
• The company plans to launch a new generation Root product this year.

Key Dates

Keywords

Masimo, proxy fight, Politan Capital, spinoff, consumer business, Stork baby monitor, Joe Kiani, board control, pulse oximetry, healthcare, OEM